[
    [
        {
            "time": "",
            "orginal_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
            "features": {
                "keywords": [
                    "齐鲁",
                    "信达",
                    "生物类似药",
                    "定价",
                    "价格战",
                    "集采"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
            "scores": {
                "News_content": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "9只个股尾盘净流入资金超亿元",
            "features": {
                "keywords": [
                    "个股",
                    "尾盘",
                    "净流入",
                    "资金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "9只个股尾盘净流入资金超亿元",
            "scores": {
                "News_content": "9只个股尾盘净流入资金超亿元",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "27亿元定增方案获受理 博雅生物拟转投华润",
            "features": {
                "keywords": [
                    "博雅生物",
                    "定增",
                    "华润",
                    "27亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "27亿元定增方案获受理 博雅生物拟转投华润",
            "scores": {
                "News_content": "27亿元定增方案获受理 博雅生物拟转投华润",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-11",
            "orginal_text": "医药行业2020年11月疫苗批签发数据跟踪报告：行业高景气，重点公司表现亮眼，维持“强于大市”评级",
            "features": {
                "keywords": [
                    "医药行业",
                    "疫苗",
                    "批签发",
                    "高景气",
                    "重点公司",
                    "强于大市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药行业2020年11月疫苗批签发数据跟踪报告：行业高景气，重点公司表现亮眼，维持“强于大市”评级",
            "scores": {
                "News_content": "医药行业2020年11月疫苗批签发数据跟踪报告：行业高景气，重点公司表现亮眼，维持“强于大市”评级",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]